Hydramine and Fingolimod drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydramine (diphenhydramine hydrochloride) and Fingolimod (fingolimod). Common drug interactions include drug ineffective among females and central nervous system lesion among males.

The phase IV clinical study analyzes what interactions people have when they take Hydramine and Fingolimod. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Hydramine?

Hydramine has active ingredients of diphenhydramine hydrochloride. It is often used in insomnia. eHealthMe is studying from 114,900 Hydramine users. Check the latest studies of Hydramine.

What is Fingolimod?

Fingolimod has active ingredients of fingolimod. eHealthMe is studying from 5,150 Fingolimod users. Check the latest studies of Fingolimod.

On Jul, 20, 2026

35 people who take Hydramine and Fingolimod together, and have interactions are studied.

Hydramine and Fingolimod drug interactions.

What are the common drug interactions of Hydramine and Fingolimod, by gender? *:

female:

Drug ineffective
Dyspnoea (difficult or laboured respiration)
Hallucination, auditory (perceiving sounds without auditory stimulus)
Chest pain
Headache (pain in head)
Heart rate decreased
Palpitations (feelings or sensations that your heart is pounding or racing)
Abdominal pain lower
Abnormal behaviour
Back pain

male:

Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Disease progression
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Kernig's sign
Lymphopenia (an abnormally low level of lymphocytes in the blood)
Nuchal rigidity (a resistance to flexion of the neck)
Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged)
Anogenital warts
Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
Brudzinski's sign (indication of meningitis)

What are the common drug interactions of Hydramine and Fingolimod, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anogenital warts

30-39:

Back pain
Dyspnoea (difficult or laboured respiration)

40-49:

Chest pain
Headache (pain in head)
Heart rate decreased
Palpitations (feelings or sensations that your heart is pounding or racing)
Abdominal pain lower
Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
Brudzinski's sign (indication of meningitis)
Cerebellar ischaemia (lack of blood supply to cerebeller)
Cough
Cryptococcosis (potentially fatal fungal disease)

50-59:

Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Disease progression
Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged)
Drug ineffective
Hallucination, auditory (perceiving sounds without auditory stimulus)
Abnormal behaviour
Fatigue (feeling of tiredness)
Headache (pain in head)
Oropharyngeal pain
Pain

60+:

n/a

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 18 people, 51.43%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 16 people, 45.71%
Migraine (headache): 5 people, 14.29%
Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 11.43%
Headache (pain in head): 4 people, 11.43%
Movement - Uncontrolled Or Slow: 3 people, 8.57%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 2 people, 5.71%
Encephalitis (inflammation of the brain): 2 people, 5.71%
Cryptococcosis (potentially fatal fungal disease): 2 people, 5.71%
Anogenital Warts: 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Hydramine and Fingolimod?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously